Skip to main content
. Author manuscript; available in PMC: 2014 Sep 1.
Published in final edited form as: Curr Vasc Pharmacol. 2013 Sep;11(5):655–711. doi: 10.2174/1570161111311050008

Table 8.

Related Calcium-Dependent Contractile Mechanisms with Development

Physiologic Variable Fetus Newborn Adult Reference
Gqα expression (in rat portal vein, % adult value) 400 to 500 100 [448]
Ins (1,4,5)P3-induced contraction (% Ca2+-induced maximum) 9±2 (35) 26±5 [357]
Ins(1,4,5)P3 Response to Norepinephrine (% of Basal) 345±27 (97) 355±23 [407]
Ins(1,4,5)P3 ·α1-AR−1 5.2±1.0c (45) 11.5±1.0 [407]
Ins(1,4,5)P3-Receptor Density (fmol·mg protein−1) 115±15 (116) 99±5 [449]
Ca2+ Mass (nmol·mg dry wt−1) 12±2b (400) 3±1 [354]
Ca2+ Mass of Ins(1,4,5)P3-Sensitive pool 1.6±0.2 (94) 1.7±0.2 [354]
Ca2+ Mass of Ryanodine-Sensitive Pool 1.2±0.1b (1200) 0.1±0.1 [354]
Calcium “sparks” Significantly less Significantly less Control value [378]
MLCK concentration (10−6M)* 1.8±0.1b (22) 8.2±0.6 [450]
(normalized to fetal value) 1.0 (26) 3.8±0.7 [451]
MLCK maximum velocity (ng MLC phosphorylated · ng MLCK−1)* 1.52±0.2b (585) 0.26±0.01 [450]
MLCK In situ Fractional Activation* 9.1±0.8b (535) 1.7±0.2 [450]
Total MLCK activity (% MLC20 phosphorylated · sec−1)* 7.39±0.53 (89) 6.56±0.29 [450]
MLCP Concentration (normalized to fetal value) 1.0 (56) 1.8±0.2 [451]
MLC20 concentration (10−6M)* 236±44 (119) 198±28 [450]
Phosphorylated/Total MLC20 (% Adult Value) (64) 100 [9]
CPI-17 – Total (% Adult Value) (15) 100 [9]
Calmodulin concentration (10−6M)* 12.4±1.3b (41) 30.6±3.7 [450]
(normalized to fetal value) 1.0 (31) 3.2±0.7 [451]
HSP-27 (normalized to fetal value) 1.0 (50) 2.0±0.2 [451]

Values are mean ±SE or 5 or more in each group;

Values in parentheses represent % of adult value;

Significantly different from adult value:

b

P<0.01;

c

P<0.05;

*

CCA